Abstract
Phenotyping and genotyping of tumor cells of various genesis provides irreplaceable information for targeted therapy. We have revealed the nanomechanical properties of living cells of cultures of primary cell lines of gliomas with the IDH1 R132H mutation, which make it possible to differentiate them from cells that do not have this mutation, which is necessary for personalized therapy of these diseases.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
